So at the end of the 30 june 2018 mesoblast had $77.763million*
*includes $40m from Novaquest paid July 10, 2018
Other funds to come
+ $40m from closing of Tasly alliance
+ Royalties from Temcell
+ Government R&D tax incentives
Other loan facilities if required
+ $15m from Hercules accessible before Q4, 2018
+$25m from Hercules accessible before Q3, 2019
+$10m from Novaquest on marketing approval of remestemcel
+ Access from Kentgrove of upto $90m from 2016 facility available within next 12 months.
All in all currently there is $77m + another US$190m available.
*have to check kentgrove facility, correct me if im wrong
So at the end of the 30 june 2018 mesoblast had $77.763million*...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.22 |
Change
-0.090(6.90%) |
Mkt cap ! $1.490B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.30 | $1.21 | $6.651M | 5.308M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 35691 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 26502 | 11 |
View Market Depth
| Last trade - 10.39am 24/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |